Premier Biomedical
Premier Biomedical, Inc.: Pioneering research-based treatments for critical human diseases.
Founded
2010Premier Biomedical, Inc.: Pioneering research-based treatments for critical human diseases.
Premier Biomedical, Inc. was founded with the core mission of discovering and developing innovative medical treatments for critical human diseases. The company focuses on addressing severe health conditions such as Alzheimer's Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Fibromyalgia, Traumatic Brain Injury, Blood Sepsis, Viremia, and Cancer. Through cutting-edge research and development, Premier Biomedical aims to provide effective therapeutic solutions that significantly improve patient outcomes and quality of life.
Notable affiliated individuals include key researchers and medical professionals dedicated to advancing the company's mission. Premier Biomedical has garnered attention from investors interested in pioneering medical technologies. The company has achieved significant milestones in its research endeavors, contributing valuable insights and potential treatments to the medical community. Overall, Premier Biomedical's impact lies in its commitment to addressing some of the most challenging diseases, thereby enhancing healthcare and offering hope to patients worldwide.
Companies similar to Premier Biomedical include Stream Biomedical, Intellimedix, Plumeria Therapeutics and Symic Biomedical.
Premier Biomedical was founded in 2010.
Premier Biomedical's headquarters is located in Port Richey, FL, US.
Premier Biomedical's most recent funding round was for $525k (USD) in December 2015.
As of Dec 30, 2015, Premier Biomedical has disclosed funding of $582k (USD). Undisclosed round amounts are excluded.
Premier Biomedical has 7 employees as of Feb 5, 2024.
Symic Biomedical
